GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker buys 1,142 Shares

December 26, 2012 | About:
insider

insider

56 followers
CEO of Progenics Pharmaceuticals, Inc. (PGNX) Mark Robert Baker buys 1,142 shares of PGNX on 12/26/2012 at an average price of $3.01 a share.

Progenics Pharmaceuticals, Inc. has a market cap of $101.4 million; its shares were traded at around $2.97 with and P/S ratio of 1.2.

This is the annual revenues and earnings per share of PGNX over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of PGNX.


CEO Recent Trades:



  • CEO Mark Robert Baker bought 1,142 shares of PGNX stock on 12/26/2012 at the average price of 3.01. Mark Robert Baker owns at least 158,014 shares after this. The price of the stock has decreased by 1.33% since.
  • CEO Mark Robert Baker bought 1,607 shares of PGNX stock on 11/28/2012 at the average price of 2.13. Mark Robert Baker owns at least 156,872 shares after this. The price of the stock has increased by 39.44% since.
  • CEO Mark Robert Baker bought 11,800 shares of PGNX stock on 11/19/2012 at the average price of 1.96. Mark Robert Baker owns at least 155,265 shares after this. The price of the stock has increased by 51.53% since.
  • CEO Mark Robert Baker bought 49,793 shares of PGNX stock on 11/16/2012 at the average price of 1.82. Mark Robert Baker owns at least 143,465 shares after this. The price of the stock has increased by 63.19% since.
  • CEO Mark Robert Baker bought 48,833 shares of PGNX stock on 11/15/2012 at the average price of 1.69. Mark Robert Baker owns at least 93,672 shares after this. The price of the stock has increased by 75.74% since.

This is the insider trade history vs. stock price of PGNX. For the complete insider trading history of PGNX, click here.




Directors and Officers Recent Trades:



  • Senior VP Medical Affairs Robert J Israel sold 1,000 shares of PGNX stock on 07/02/2012 at the average price of 9.79. Robert J Israel owns at least 35,050 shares after this. The price of the stock has decreased by 69.66% since.


For the complete insider trading history of PGNX, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.8/5 (4 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK